Annual Revenue
$488.00 K
+$102.00 K+26.42%
31 December 2023
Summary:
Cardiff Oncology annual revenue is currently $488.00 thousand, with the most recent change of +$102.00 thousand (+26.42%) on 31 December 2023. During the last 3 years, it has risen by +$122.00 thousand (+33.33%). CRDF annual revenue is now -3.44% below its all-time high of $505.40 thousand, reached on 31 December 2017.CRDF Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$165.00 K
+$2000.00+1.23%
30 September 2024
Summary:
Cardiff Oncology quarterly revenue is currently $165.00 thousand, with the most recent change of +$2000.00 (+1.23%) on 30 September 2024. Over the past year, it has increased by +$24.00 thousand (+17.02%). CRDF quarterly revenue is now -21.99% below its all-time high of $211.50 thousand, reached on 30 September 2012.CRDF Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$689.00 K
+$24.00 K+3.61%
30 September 2024
Summary:
Cardiff Oncology TTM revenue is currently $689.00 thousand, with the most recent change of +$24.00 thousand (+3.61%) on 30 September 2024. Over the past year, it has increased by +$229.00 thousand (+49.78%). CRDF TTM revenue is now at all-time high.CRDF TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDF Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.4% | +17.0% | +49.8% |
| 3 y3 years | +33.3% | +91.9% | +99.7% |
| 5 y5 years | +29.0% | +219.2% | +199.6% |
CRDF Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +35.9% | -19.5% | +123.0% | at high | +99.7% |
| 5 y | 5 years | at high | +99.5% | -19.5% | +283.7% | at high | +199.6% |
| alltime | all time | -3.4% | +99.5% | -22.0% | +388.2% | at high | +673.3% |
Cardiff Oncology Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $165.00 K(+1.2%) | $689.00 K(+3.6%) |
| June 2024 | - | $163.00 K(-20.5%) | $665.00 K(+9.0%) |
| Mar 2024 | - | $205.00 K(+31.4%) | $610.00 K(+25.0%) |
| Dec 2023 | $488.00 K(+26.4%) | $156.00 K(+10.6%) | $488.00 K(+6.1%) |
| Sept 2023 | - | $141.00 K(+30.6%) | $460.00 K(+11.7%) |
| June 2023 | - | $108.00 K(+30.1%) | $412.00 K(+4.3%) |
| Mar 2023 | - | $83.00 K(-35.2%) | $395.00 K(+2.3%) |
| Dec 2022 | $386.00 K(+7.5%) | $128.00 K(+37.6%) | $386.00 K(-1.3%) |
| Sept 2022 | - | $93.00 K(+2.2%) | $391.00 K(+1.8%) |
| June 2022 | - | $91.00 K(+23.0%) | $384.00 K(+6.4%) |
| Mar 2022 | - | $74.00 K(-44.4%) | $361.00 K(+0.6%) |
| Dec 2021 | $359.00 K(-1.9%) | $133.00 K(+54.7%) | $359.00 K(+4.1%) |
| Sept 2021 | - | $86.00 K(+26.5%) | $345.00 K(-12.7%) |
| June 2021 | - | $68.00 K(-5.6%) | $395.00 K(+6.8%) |
| Mar 2021 | - | $72.00 K(-39.5%) | $370.00 K(+1.1%) |
| Dec 2020 | $366.00 K(+49.6%) | $119.00 K(-12.5%) | $366.00 K(+7.8%) |
| Sept 2020 | - | $136.00 K(+216.3%) | $339.60 K(+33.0%) |
| June 2020 | - | $43.00 K(-36.8%) | $255.30 K(+1.9%) |
| Mar 2020 | - | $68.00 K(-26.6%) | $250.60 K(+2.5%) |
| Dec 2019 | $244.60 K(-35.3%) | $92.60 K(+79.1%) | $244.60 K(+6.3%) |
| Sept 2019 | - | $51.70 K(+35.0%) | $230.00 K(-13.8%) |
| June 2019 | - | $38.30 K(-38.2%) | $266.70 K(-21.6%) |
| Mar 2019 | - | $62.00 K(-20.5%) | $340.20 K(-10.1%) |
| Dec 2018 | $378.30 K(-25.1%) | $78.00 K(-11.8%) | $378.30 K(-22.0%) |
| Sept 2018 | - | $88.40 K(-20.9%) | $485.30 K(-6.7%) |
| June 2018 | - | $111.80 K(+11.7%) | $520.20 K(+1.9%) |
| Mar 2018 | - | $100.10 K(-45.9%) | $510.40 K(+1.0%) |
| Dec 2017 | $505.40 K | $185.00 K(+50.0%) | $505.30 K(+30.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $123.30 K(+20.9%) | $388.40 K(+9.7%) |
| June 2017 | - | $102.00 K(+7.4%) | $354.20 K(-0.4%) |
| Mar 2017 | - | $95.00 K(+39.5%) | $355.60 K(-6.7%) |
| Dec 2016 | $381.10 K(+21.8%) | $68.10 K(-23.6%) | $381.10 K(-2.8%) |
| Sept 2016 | - | $89.10 K(-13.8%) | $392.20 K(+8.8%) |
| June 2016 | - | $103.40 K(-14.2%) | $360.40 K(+14.2%) |
| Mar 2016 | - | $120.50 K(+52.1%) | $315.50 K(-2.0%) |
| Dec 2015 | $312.80 K(+11.6%) | $79.20 K(+38.2%) | $322.00 K(+7.6%) |
| Sept 2015 | - | $57.30 K(-2.1%) | $299.20 K(+0.0%) |
| June 2015 | - | $58.50 K(-53.9%) | $299.10 K(+1.0%) |
| Mar 2015 | - | $127.00 K(+125.2%) | $296.20 K(+5.7%) |
| Dec 2014 | $280.20 K(+8.1%) | $56.40 K(-1.4%) | $280.20 K(+3.3%) |
| Sept 2014 | - | $57.20 K(+2.9%) | $271.20 K(+5.2%) |
| June 2014 | - | $55.60 K(-49.9%) | $257.80 K(+2.6%) |
| Mar 2014 | - | $111.00 K(+134.2%) | $251.20 K(-3.1%) |
| Dec 2013 | $259.20 K(-42.5%) | $47.40 K(+8.2%) | $259.30 K(-30.9%) |
| Sept 2013 | - | $43.80 K(-10.6%) | $375.20 K(-30.9%) |
| June 2013 | - | $49.00 K(-58.9%) | $542.90 K(+1.4%) |
| Mar 2013 | - | $119.10 K(-27.1%) | $535.40 K(+18.8%) |
| Dec 2012 | $450.40 K(+74.8%) | $163.30 K(-22.8%) | $450.50 K(+40.3%) |
| Sept 2012 | - | $211.50 K(+409.6%) | $321.00 K(+95.1%) |
| June 2012 | - | $41.50 K(+21.3%) | $164.50 K(-18.9%) |
| Mar 2012 | - | $34.20 K(+1.2%) | $202.90 K(-21.3%) |
| Dec 2011 | $257.70 K(-3.0%) | $33.80 K(-38.5%) | $257.80 K(+15.1%) |
| Sept 2011 | - | $55.00 K(-31.2%) | $224.00 K(+32.5%) |
| June 2011 | - | $79.90 K(-10.3%) | $169.00 K(+89.7%) |
| Mar 2011 | - | $89.10 K | $89.10 K |
| Dec 2010 | $265.70 K | - | - |
FAQ
- What is Cardiff Oncology annual revenue?
- What is the all time high annual revenue for Cardiff Oncology?
- What is Cardiff Oncology annual revenue year-on-year change?
- What is Cardiff Oncology quarterly revenue?
- What is the all time high quarterly revenue for Cardiff Oncology?
- What is Cardiff Oncology quarterly revenue year-on-year change?
- What is Cardiff Oncology TTM revenue?
- What is the all time high TTM revenue for Cardiff Oncology?
- What is Cardiff Oncology TTM revenue year-on-year change?
What is Cardiff Oncology annual revenue?
The current annual revenue of CRDF is $488.00 K
What is the all time high annual revenue for Cardiff Oncology?
Cardiff Oncology all-time high annual revenue is $505.40 K
What is Cardiff Oncology annual revenue year-on-year change?
Over the past year, CRDF annual revenue has changed by +$102.00 K (+26.42%)
What is Cardiff Oncology quarterly revenue?
The current quarterly revenue of CRDF is $165.00 K
What is the all time high quarterly revenue for Cardiff Oncology?
Cardiff Oncology all-time high quarterly revenue is $211.50 K
What is Cardiff Oncology quarterly revenue year-on-year change?
Over the past year, CRDF quarterly revenue has changed by +$24.00 K (+17.02%)
What is Cardiff Oncology TTM revenue?
The current TTM revenue of CRDF is $689.00 K
What is the all time high TTM revenue for Cardiff Oncology?
Cardiff Oncology all-time high TTM revenue is $689.00 K
What is Cardiff Oncology TTM revenue year-on-year change?
Over the past year, CRDF TTM revenue has changed by +$229.00 K (+49.78%)